Matinas BioPharma Holdings Inc (MTNB)
0.165
0.00 (0.00%)
USD |
NYAM |
May 23, 10:24
Matinas BioPharma Holdings Shareholders Equity (Quarterly): 14.56M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 14.56M |
| December 31, 2023 | 19.25M |
| September 30, 2023 | 23.15M |
| June 30, 2023 | 27.85M |
| March 31, 2023 | 32.62M |
| December 31, 2022 | 36.64M |
| September 30, 2022 | 38.62M |
| June 30, 2022 | 42.85M |
| March 31, 2022 | 47.68M |
| December 31, 2021 | 52.49M |
| September 30, 2021 | 58.25M |
| June 30, 2021 | 62.90M |
| March 31, 2021 | 66.56M |
| December 31, 2020 | 63.73M |
| September 30, 2020 | 68.21M |
| June 30, 2020 | 72.82M |
| March 31, 2020 | 77.60M |
| December 31, 2019 | 33.05M |
| September 30, 2019 | 37.98M |
| June 30, 2019 | 40.42M |
| March 31, 2019 | 43.01M |
| Date | Value |
|---|---|
| December 31, 2018 | 16.14M |
| September 30, 2018 | 10.30M |
| June 30, 2018 | 12.53M |
| March 31, 2018 | 8.434M |
| December 31, 2017 | 10.68M |
| September 30, 2017 | 12.78M |
| June 30, 2017 | 15.21M |
| March 31, 2017 | 18.86M |
| December 31, 2016 | 7.15M |
| September 30, 2016 | 8.722M |
| June 30, 2016 | 2.997M |
| March 31, 2016 | 4.220M |
| December 31, 2015 | 6.072M |
| September 30, 2015 | 6.961M |
| June 30, 2015 | 8.629M |
| March 31, 2015 | 6.393M |
| December 31, 2014 | 2.228M |
| September 30, 2014 | 4.746M |
| June 30, 2014 | 6.458M |
| March 31, 2014 | 8.610M |
| December 31, 2013 | 10.47M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
14.56M
Minimum
Mar 2024
77.60M
Maximum
Mar 2020
45.86M
Average
41.63M
Median
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 0.16M |
| Palatin Technologies Inc | 1.579M |
| iBio Inc | 24.86M |
| Theriva Biologics Inc | 34.12M |
| Oragenics Inc | 2.625M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 19.61M |
| Total Liabilities (Quarterly) | 5.052M |